Cargando…

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera

Mass-vaccination against COVID-19 is still a distant goal for most low-to-middle income countries. The experience gained through decades producing polyclonal immunotherapeutics (such as antivenoms) in many of those countries is being redirected to develop similar products able to neutralize SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales:	González Viacava, Myriam Belén, Varese, Augusto, Mazzitelli, Ignacio, Lanari, Laura, Ávila, Lucía, García Vampa, María Julia, Geffner, Jorge, Cascone, Osvaldo, Dokmetjian, José Christian, de Roodt, Adolfo Rafael, Fingermann, Matías
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788445/ https://www.ncbi.nlm.nih.gov/pubmed/35076465 http://dx.doi.org/10.3390/antib11010003

Ejemplares similares

Biotechnological potential of Phospholipase D for Loxosceles antivenom development
por: Fingermann, Matías, et al.
Publicado: (2020)

RHEUMATOID FACTOR PROPERTIES OF HYPERIMMUNE RABBIT SERA
por: Christian, Charles L.
Publicado: (1963)

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays
por: Ferrara, Francesca, et al.
Publicado: (2017)

Development of an ELISA for distinguishing convalescent sera with Mycoplasma hyopneumoniae infection from hyperimmune sera responses to bacterin vaccination in pigs
por: Ding, Honglei, et al.
Publicado: (2021)

COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus
por: da Costa, Camila B.P., et al.
Publicado: (2021)

Equine hyperimmune serum protects mice against Clostridium difficile spore challenge
por: Yan, Weiwei, et al.
Publicado: (2014)

Production of the First Effective Hyperimmune Equine Serum Antivenom against Africanized Bees
por: Santos, Keity Souza, et al.
Publicado: (2013)

Fully Automated Screening of a Combinatorial Library to Avoid False Positives: Application to Tetanus Toxoid Ligand Identification
por: Martínez Ceron, María C., et al.
Publicado: (2021)

OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves
por: Fingermann, Matias, et al.
Publicado: (2018)

Development of an indirect ELISA for detecting humoral immunodominant proteins of Mycoplasma hyopneumoniae which can discriminate between inactivated bacterin-induced hyperimmune sera and convalescent sera
por: Ding, Honglei, et al.
Publicado: (2019)

Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection
por: Zheng, Xuexing, et al.
Publicado: (2016)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi
por: Harvey, Aja B., et al.
Publicado: (2020)

Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection
por: Li, Entao, et al.
Publicado: (2023)

Preparation and development of equine hyperimmune globulin F(ab′)(2) against severe acute respiratory syndrome coronavirus
por: LU, Jai‐hai, et al.
Publicado: (2005)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')(2 )in mice
por: Lu, Jiahai, et al.
Publicado: (2006)

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2
por: Aston, Emily J., et al.
Publicado: (2022)

Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections
por: Singh, Gagandeep, et al.
Publicado: (2023)

Molecular Prevalence of Equine Parvovirus-Hepatitis in the Sera of Clinically Healthy Horses in South Korea
por: Lee, Sang-Kyu, et al.
Publicado: (2021)

COVID-19 and Territorial Policy Dynamics in Western Europe: Comparing France, Spain, Italy, Germany, and the United Kingdom
por: Vampa, Davide
Publicado: (2021)

GAMMA GLOBULIN TURNOVER IN RABBITS BEFORE AND DURING HYPERIMMUNIZATION
por: Andersen, Stig Bryde, et al.
Publicado: (1964)

Prevention and Treatment of Influenza with Hyperimmune Bovine Colostrum Antibody
por: Ng, Wy Ching, et al.
Publicado: (2010)

Herd immunity: hyperimmune globulins for the 21st century
por: Elliott, Sarah TC, et al.
Publicado: (2018)

Avid Editing
por: Kauffmann, Sam, et al.
Publicado: (2017)

An Avid Imitator
por: Farmakiotis, Dimitrios, et al.
Publicado: (2016)

Editing with Avid Media Composer 5: the official Avid guide.
por: Kennedy, Ashley
Publicado: (2010)

Anti-SARS-CoV-2 hyperimmune plasma workflow
por: Annamaria, Petrungaro, et al.
Publicado: (2020)

Neonatal foals and hyperimmunized egg protein—A viable therapy?
por: Bennett-Steward, Kristina
Publicado: (2002)

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023)

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
por: Tang, Juanjie, et al.
Publicado: (2021)

OCCURRENCE OF 19S AND 7S ANTI-IGGS DURING HYPERIMMUNIZATION OF RABBITS WITH STREPTOCOCCI
por: Bokisch, Viktor A., et al.
Publicado: (1972)

CHARACTERISTICS OF STREPTOCOCCAL GROUP-SPECIFIC ANTIBODY ISOLATED FROM HYPERIMMUNE RABBITS
por: Osterland, C. Kirk, et al.
Publicado: (1966)

Wilson disease — the impact of hyperimmunity on disease activity: A case report
por: Stremmel, Wolfgang, et al.
Publicado: (2021)

Generation of recombinant hyperimmune globulins from diverse B-cell repertoires
por: Keating, Sheila M., et al.
Publicado: (2021)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

Transfusion reaction to hyperimmune plasma in patients with severe COVID-19 infection()
por: Edroso Jarne, Paloma Eugenia, et al.
Publicado: (2021)

Serum proteins and electrophoretic profile in horses undergoing crotalid venom hyperimmunization
por: RAMOS, Monique Gonçalves dos Santos Novelino, et al.
Publicado: (2022)

Novel insights in the clinical management of hyperimmune patients before and after transplantation
por: Grimaldi, Vincenzo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p82j4b7en0c6ff7i7p6ujkvej1